Cargando…
Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools()
BACKGROUND & AIMS: Cystic Fibrosis related liver disease (CFLD) is the 3rd largest cause of death in Cystic Fibrosis (CF). As advances in pulmonary therapies have increased life-expectancy, CFLD has become more prevalent. Current guidelines may underdiagnose liver fibrosis, particularly in its e...
Autores principales: | Scott, Jennifer A., Jones, Andrew M., Jokl, Elliot, Gordon-Walker, Timothy, Barry, Peter J., Hanley, Neil A., Piper Hanley, Karen, Athwal, Varinder S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694159/ http://dx.doi.org/10.1016/j.heliyon.2023.e21861 |
Ejemplares similares
-
Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications
por: Martin, Katherine, et al.
Publicado: (2021) -
PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis
por: Martin, Katherine, et al.
Publicado: (2016) -
SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis
por: Athwal, Varinder S., et al.
Publicado: (2018) -
Publisher Correction: SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosis
por: Athwal, Varinder S., et al.
Publicado: (2019) -
Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease
por: Jokl, Elliot, et al.
Publicado: (2023)